HCV抗原、HCV抗体及HCV-RNA联合检测与ALT的相关性及其临床意义

邵芳. HCV抗原、HCV抗体及HCV-RNA联合检测与ALT的相关性及其临床意义[J]. 中国中西医结合消化杂志, 2014, 22(2): 80-82. doi: 10.3969/j.issn.1671-038X.2014.02.07
引用本文: 邵芳. HCV抗原、HCV抗体及HCV-RNA联合检测与ALT的相关性及其临床意义[J]. 中国中西医结合消化杂志, 2014, 22(2): 80-82. doi: 10.3969/j.issn.1671-038X.2014.02.07
SHAO Fang. Clinical significance of joint detection of HCV antigen,HCV antibody and HCV RNA,and its correlation analysis with ALT[J]. Chin J Integr Tradit West Med Dig, 2014, 22(2): 80-82. doi: 10.3969/j.issn.1671-038X.2014.02.07
Citation: SHAO Fang. Clinical significance of joint detection of HCV antigen,HCV antibody and HCV RNA,and its correlation analysis with ALT[J]. Chin J Integr Tradit West Med Dig, 2014, 22(2): 80-82. doi: 10.3969/j.issn.1671-038X.2014.02.07

HCV抗原、HCV抗体及HCV-RNA联合检测与ALT的相关性及其临床意义

详细信息
    作者简介:

    邵芳,主管技师,从事医学检验工作

  • 中图分类号: R575.1

Clinical significance of joint detection of HCV antigen,HCV antibody and HCV RNA,and its correlation analysis with ALT

  • [目的]探讨HCV-RNA阳性丙肝患者核心抗原(HCV-cAg)、抗体(HCV -Ab)以及HCV-RNA含量3种检测指标与丙氨酸氨基转移酶(ALT)水平的相关性及其临床意义。[方法]对100例HCV-RNA阳性丙肝患者应用酶速率法检测ALT含量、ELISA法检测HCV-cAg、CLIA法检测HCV-Ab、FQ-PCR法检测HCV-RNA,并对所得数据进行统计分析。[结果]100例患者血清中HCV-Ab阳性率为97.0%,HCV-cAg阳性率为83.0%;HCV-RNA载体含量越高,HCV-Ab阳性率越高;ALT含量的变化与HCV-RNA载体含量并无明显相关性(P>0.05);ALT异常率随着HCV-RNA含量的增高而升高,呈正相关(P<0.05)。[结论]HCV-Ab检测可反映机体对HCV感染的免疫状态,能间接证实HCV感染;HCV-RNA敏感性和特异性较高,HCV-RNA与HCV-cAg阳性检出率呈现一致性,且ALT异常率随着HCV-RNA含量的增高而升高,可以反映临床病情;3种方法同时检测能准确诊断丙肝病毒的感染,以及预测是否具有传染性,联合ALT可有效预测和评价肝脏损伤和药物疗效。
  • 加载中
  • [1]

    秦艳兰, 刘仁强, 刘景春, 等.丙型肝炎病毒抗体 (抗-HCV) 诊断试剂盒质检评价分析[J].细胞与分子免疫学杂志, 2009, 25 (2):139-140.

    [2]

    王晗, 李伯安, 李永利, 等.丙型肝炎抗体的检测与HCV RNA定量及ALT的关系探讨[J].传染病信息, 2007, 20 (5):293-296.

    [3]

    PUOTI C, GUARISCO R, BELLIS L, et al.Diagnosis, management, and treatment of hepatitis C[J].Hepatology, 2009, 50:322-325.

    [4]

    DURU M U, ALUYI H S, ANUKAM K C.Rapid screening for co-infection of HIV and HCV in pregnant women in Benin City, Edo State, Nigeria[J].Afr Health Sci, 2009, 9:137-142.

    [5]

    SHIMAKAMI T, LANFORD R E, LEMON S M.Hepatitis C:recent successes and continuing challenges in the development of improved treatment modalities[J].Curr Opin Pharmacol, 2009, 9:537-544.

    [6]

    DE BRUIJNE J, SULLIVAN J C, KIEFFER T L, et al.Dynamic changes in HCV RNA levels and viral quasispecies in a patient with chronic hepatitis C after telaprevir-based treatment[J].J Clin Virol, 2012, 53:174-177.

    [7]

    EL-SHAMY A, SHOJI I, KIM S R, et al.Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2band clinical outcome of pegylated-interferon/ribavirin therapy[J].PLoS One, 2012, 7:e30513-30513.

    [8]

    LAI K K, JIN M, YUAN S, et al.Improved reflexive testing algorithm for hepatitis C infection using signalto-cutoff ratios of a hepatitis C virus antibody assay[J].Clin Chem, 2011, 57:1050-1056.

  • 加载中
计量
  • 文章访问数:  60
  • PDF下载数:  70
  • 施引文献:  0
出版历程
收稿日期:  2013-10-20

目录